Polymorphism of the renalase gene in end-stage renal disease patients affected by hypertension

Nephrology Dialysis Transplantation

Volumn 27, Issue 11, 2012, Pages 4162-4166

  Stec, Anna ^a   Semczuk, Andrzej ^a   Furmaga, Jacek ^a   Ksiazek, Andrzej ^a   Buraczynska, Monika ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

end stage renal disease; hypertension; polymorphism; renalase; single nucleotide

Indexed keywords

GENOMIC DNA; MEMBRANE PROTEIN; PROTEIN MSP 1; PROTEIN PST 1; RESTRICTION ENDONUCLEASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEMODIALYSIS PATIENT; HETEROZYGOTE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CLEAVAGE; RENAL REPLACEMENT THERAPY; RENALASE GENE;

ADULT; AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MONOAMINE OXIDASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RENAL DIALYSIS;

EID: 84869409374     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr293     Document Type: Article

References (27)

1. Xu J, Guoyong L, Wang P et al. Renalase is a novel, soluble mono-amine oxidase that regulates cardiac function and blood pressure. J Clin Invest 2005; 115:1275-1280. (Pubitemid 40629046)
2. Pandini V, Ciriello F, Tedeschi G et al. Synthesis of human renalase1 in Escherichia coli and its purification as a FAD-containing holopro-tein. Protein Expr Purif 2010; 72:244-253.
3. Wang J, Edmondson DE. Do monomeric vs dimeric forms of MAO-A make a difference? A direct comparison of the catalytic properties of rat and human MAO-A's. J Neural Transm 2007; 114:721-724. (Pubitemid 46980475)
4. Binda C, Hubálek F, Li M et al. Crystal structure of human mono-amine oxidase B, a drug target enzyme monotopically inserted into the mitochondrial outer membrane. FEBS Lett 2004; 30:225-228. (Pubitemid 38520924)
5. Wang J, Qi S, Cheng W et al. Identification, expression and tissue distribution of a renalase homologue from mouse. Mol Biol Rep 2008; 35:613-620.
6. Hennebry SC, Eikelis N, Socratous F et al. Renalase, a novel soluble FAD-dependent protein, is synthesized in the brain and peripheral nerves. Mol Psychiatry 2010; 15:234-236.
7. Boomsma F, Tipton KF. Renalase, a catecholamine-metabolising enzyme? J Neural Transm 2007; 114:775-776. (Pubitemid 46980469)
8. Luft FC. Renalase, a catecholamine-metabolizing hormone from the kidney. Cell Metab 2005; 1:358-360. (Pubitemid 43960630)
9. Desir GV. Renalase deficiency in chronic kidney disease, and its contribution to hypertension and cardiovascular disease. Curr Opin Nephrol Hypertens 2008; 17:181-185. (Pubitemid 351253044)
10. Li G, Xu J, Wang P et al. Catecholamines regulate the activity, secretion, and synthesis of renalase. Circulation 2008; 11:1277-1282. (Pubitemid 351365660)
11. Xu J, Desir GV. Renalase, a new renal hormone: its role in health and disease. Curr Opin Nephrol Hypertens 2007; 16:373-378. (Pubitemid 46944337)
12. Desir GV. Renalase is a novel renal hormone that regulates cardiovascular function. J Am Soc Hypertens 2007; 1:99-103. (Pubitemid 46710832)
13. Desir GV. Regulation of blood pressure and cardiovascular function by renalase. Kidney Int 2009; 76:366-370.
14. Schlaich MP, Socratous F, Hennebry S et al. Sympathetic activation in chronic renal failure. J Am Soc Nephrol 2009; 20:933-939.
15. Joles JA, Koomans HA. Causes and consequences of increased sympathetic activity in renal disease. Hypertension 2004; 43:699-704.
16. Farzaneh-Far R, Desir GV, Na B et al. A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul study. PLoS One 2010; 5: e13496
17. Madisen L, Hoar DI, Holroyd CD et al. The banking: the effects of storage of blood and isolated DNA on the integrity of DNA. Am J Med Genet 1987; 27:379-390. (Pubitemid 17082383)
18. Mullis K. The unusual origin of the polymerase chain reaction. Sci Am 1990; 262:56-65. (Pubitemid 20084787)
19. Oparil S, Zaman MA, Calhoun DA. Pathogenesis of hypertension. Ann Intern Med 2003; 139:761-776. (Pubitemid 38139234)
20. Paulis L, Unger T. Novel therapeutic targets for hypertension. Nat Rev Cardiol 2010; 7:431-441.
21. Jeunemaitre X, Gimenez-Roqueplo AP, Disse-Nicodeme S, Corvol P. Molecular basis of human hypertension. In: Rimoin DL, Connor JM, Pyeritz RE, Korf BR eds. Emery and Rimon's Principles and Practice of Medical Genetics, 5th edn. Philadelphia, PA: Churchill Livingstone, 2007:1283-1300.
22. Dongfeng G, Shaoyong S, Dongliang G et al. Association study with 33 single-nucleotide polymorphisms in 11 candidate genes for hypertension in Chinese. Hypertension 2006; 47:1147-1154.
23. Wilson FH, Disse-Nicodeme S, Choate KA et al. Human hypertension caused by mutations in WNK kinases. Science 2001; 293:1107-1112. (Pubitemid 32758085)
24. Zhao Q, Fan Z, He J et al. Renalase gene is a novel susceptibility gene for essential hypertension: a two-stage association study in northern Han Chinese population. J Mol Med 2007; 85:877-885. (Pubitemid 47077106)
25. Santos SF, Peixoto AJ. Hypertension in dialysis. Curr Opin Nephrol Hypertens 2005; 14:111-118. (Pubitemid 40396863)
26. Lameire N. Cardiovascular problems in ESRD patients. Nefrologia 2000; 20 (Suppl 3):33-40.
27. Received for publication:15.9.2010; Accepted in revised form:26.4.2011